Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
68,022,562
-
Share change
-
+1,007,161
-
Total reported value
-
$398,611,098
-
Put/Call ratio
-
147%
-
Price per share
-
$5.86
-
Number of holders
-
120
-
Value change
-
+$6,619,972
-
Number of buys
-
52
-
Number of sells
-
49
Institutional Holders of KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) as of Q4 2016
As of 31 Dec 2016,
KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) was held by
120 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,022,562 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, ABRAMS CAPITAL MANAGEMENT, L.P., STATE STREET CORP, BlackRock Institutional Trust Company, N.A., FMR LLC, BlackRock Fund Advisors, AMERIPRISE FINANCIAL INC, NORGES BANK, and Bank of New York Mellon Corp.
This page lists
120
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.